Ellen Goldberg
Director/Board Member chez CASTLE BIOSCIENCES, INC.
Fortune : 210 536 $ au 31/03/2024
Profil
Ellen Goldberg is an Independent Director at Castle Biosciences, Inc. She previously worked as the Vice President-Marketing at Crescendo Bioscience LLC from 2009 to 2011.
Ms. Goldberg holds a graduate degree and an MBA from Stanford University.
She also has an undergraduate degree from Yale University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0,03% | 14/07/2023 | 9 505 ( 0,03% ) | 210 536 $ | 31/03/2024 |
Postes actifs de Ellen Goldberg
| Sociétés | Poste | Début |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Director/Board Member | 16/07/2021 |
Anciens postes connus de Ellen Goldberg
| Sociétés | Poste | Fin |
|---|---|---|
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Sales & Marketing | 01/01/2011 |
Formation de Ellen Goldberg
| Stanford University | Graduate Degree |
| Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
